Akagbosu, Blossom
Tayyebi, Zakieh http://orcid.org/0000-0002-7821-9905
Shibu, Gayathri
Paucar Iza, Yoselin A.
Deep, Deeksha
Parisotto, Yollanda Franco
Fisher, Logan http://orcid.org/0000-0003-4680-1527
Pasolli, H. Amalia
Thevin, Valentin http://orcid.org/0000-0002-0548-1160
Elmentaite, Rasa http://orcid.org/0000-0001-7366-5466
Knott, Maximilian http://orcid.org/0000-0002-6995-3702
Hemmers, Saskia http://orcid.org/0000-0002-5575-0509
Jahn, Lorenz http://orcid.org/0000-0002-9880-7026
Friedrich, Christin
Verter, Jacob http://orcid.org/0000-0003-3710-6549
Wang, Zhong-Min http://orcid.org/0000-0002-5538-1969
van den Brink, Marcel http://orcid.org/0000-0003-0696-4401
Gasteiger, Georg http://orcid.org/0000-0001-6986-127X
Grünewald, Thomas G. P. http://orcid.org/0000-0003-0920-7377
Marie, Julien C. http://orcid.org/0000-0001-6713-7923
Leslie, Christina http://orcid.org/0000-0002-4571-5910
Rudensky, Alexander Y. http://orcid.org/0000-0003-1280-2898
Brown, Chrysothemis C. http://orcid.org/0000-0002-5834-926X
Article History
Received: 9 May 2021
Accepted: 1 September 2022
First Online: 7 September 2022
Competing interests
: M.v.d.B. has received research support and stock options from Seres Therapeutics and stock options from Notch Therapeutics and Pluto Therapeutics; he has received royalties from Wolters Kluwer; has consulted, received honorarium from or participated in advisory boards for Seres Therapeutics, WindMIL Therapeutics, Rheos Medicines, Merck & Co., Magenta Therapeutics, Frazier Healthcare Partners, Nektar Therapeutics, Notch Therapeutics, Forty Seven, Priothera, Ceramedix, Lygenesis, Pluto Therapeutics, GlaskoSmithKline, Da Volterra, Vor BioPharma, Novartis (spouse), Synthekine (spouse) and Beigene (spouse); he has intellectual property licensed to Seres Therapeutics and Juno Therapeutics; and holds a fiduciary role on the Foundation Board of DKMS (a nonprofit organization). A.Y.R. is a member of the scientific advisory board and has equity in Surface Oncology and RAPT Therapeutics, and holds intellectual property licensed to Takeda, which is not related to the content of this study.